Member Info for Toffy

The RNS this morning contains this key information which perhaps should have been a separate RNS of its own:

“The Company anticipates launching the Genedrive® 96-SARS-CoV-2 in May 2020 at an estimated price of £8-10 per test. The Company will address the market on a non-exclusive basis with sales through an appropriate mix of distributors and direct to customers. The Directors believe that based on its sales volume forecasts and estimates of selling prices in the market, the Company will be able to achieve attractive gross margins of at least 60%, noting genedrive does not fully absorb labour costs into its margins.“

The others (NCYT ODX etc) haven’t released any info on profit margins. It’s great GDR have done this.

There is so much positive news in the RNS which would ordinarily have sent the sp flying. Unfortunately that news is buried deep within the RNS.

Two positive RNS in two day - but combined with placing. That’s why we’re only up 10% today.

I’m glad I went back in after the panic sale.

I did a lot of research on GDR and think it has the potential to have minimum £200m MC (which would be the same as AVCT and NCYT) very shortly. That’s why I traded a large sum of money. I was just so stunned by what happened that I had to sell and get out.

Back in now and I’m recovering some of the loses already.

I usually onIy trade in FTSE100 companies and never seen anything like this.

I’m mightily annoyed at how this was done. Why not release RNS outside trading hours?

And the RNS contained lots of positive news which was buried several pages in.

I panicked sold. Now bought back in and lost several thousand pounds in the process. I know some will say it’s my own fault, but this is not how markets are supposed to behave.

This is bouncing up and down like a yoyo. It seems to have gone about 50% up and then 75% down, and now 30% up again.

I just hope I don't get spiked for a second time today.

I am such a tool. I bought at 200. Sold in panic this morning at 170. Now bought back at 200.

In the process I lost a few grand.

Oh dear! Seems to be rising again. I sold at lowest drop

I am just so shuck by what just happened. And kinda lost faith in the company tbh

Honestly, should I look to go back in? - without any ramping or deramping.

My timing is always the worst with both purchases and sales.

No financial hardship thankfully. But it wasn't fun losing money in minutes.

Does anyone else feel a little cheated by positive RNS after closing yesterday and then dumping this on us today after opening? Shakes confidence in the company

I may regret selling. But I just don't feel comfortable with this. If it drops further I might come back in, otherwise I will go elsewhere.

Sold at a significant loss. I will look for a moment to re-enter.

Who can buy in placing? Are these shares going to be up for sale to the general public?

Could someone explain placing to me? They are selling shares for 80p? Who can buy these shares?

Also has anyone managed to successfully sell In last 5 minutes? I have tried but no success

Wait - are you saying ODX are not manufacturers?

Are you saying they invent the tests?

The reason ODX are in the consortium is precisely because they are manufacturers. They make good tests. Someone else will invent it, ODX will make it. That’s also the agreement with Mologic - Mologic created a test and ODX will now help make it.

There is certainly a profit to be had from manufacturing the tests. That’s why I said it would be useful to know the profit margins and manufacturing capacity.

Who is inventing the tests?

ODX are only the manufacturers. Not designers or inventors. It appears the inventors are academics at Oxford with some other scientists. The Consortium contains some manufacturers who will then make the tests.

I assume it won’t be patented by who ever is inventing this test.

ODX need to provide an update on: 1) manufacturing capacity; 2) profit margin. Both are very important to decide if the current £100m market cap is justified.

I think you misunderstood my point. My point is that this is a company which is currently hugely undervalued. Some companies are already bloated and don’t have much further to go. Whereas with MC of £70m, GDR could increase three fold and still only be the same size as AVCT and NCYT are currently.

Share price is a little irrelevant. The price depends on the number of shares outstanding.

We should instead look at GDR's market cap. It is around £70m at the moment. Serious investors will be looking at where the market cap could rise to in the future.

Lets compare GDR to other companies' MC:

NCYT: £250m
AVCT: £240m
ODX: £98m

What’s hilarious about ODX crew is that they don’t actually realise ODX are only manufacturers. They don’t invent - they make. They will make tests which are invented by others. There will be a profit to be had from manufacturing, but not a huge one. At the moment ODX have limited manufacturing capability. The big pharma are easily able to upscale manufacturing.

NCYT invented their test. Then partnered with others to upscale manufacturing.

GDR likewise invented a test. Need to get it approved, then upscale manufacturing. Partnering with big pharma to upscale manufacturing is GDRs approach too.

The real money is in invention, not simply manufacturing.